In addition, these SCFAs have been demonstrated to increase the production of anti-inflammatory gut hormones in enteroendocrine cells, including GLP-1 and GLP-2 [51], which are both known for beneficial effects against cardiovascular disease [52,53]. This evidence concerns the gene GCG and cardiovascular disorder.